Mankind Pharma acquires two derma and respiratory brands from Dr Reddy's

Mankind Pharma to take over manufacturing, marketing and distribution of both products in India; entire integration and transition of the brands likely to be completed by March

After acquiring the domestic formulations business of Panacea Biotec, India's fourth largest pharma company Mankind Pharma on Wednesday said that it has entered into an agreement with Dr Reddy's Laboratories (DRL) to acquire two of its brands - one asthma and one infant care brand. The deal size was not disclosed. 

Combihale, a drug used for treating asthma and chronic obstructive pulmonary disease has a category market size of Rs 900 crore which is growing at 14 percent (IQVIA). Daffy, a soap-free moisturising bar for infants operates in a market category which is valued at Rs 1000 crore and is